Ozempic and other GLP-1 weight loss drugs may slow biological aging, according to a new study.
The research, published earlier this week by the University of California at San Diego, revealed that semaglutide GLP-1s may be reprogramming cells to boost immune health and reducing inflammation, slowing the body’s decline at a cellular level.
